Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro
A new study suggests that modified natural killer cells, which express a chimeric antigen receptor using S309 antibody, can bind to and inactivate SARS-CoV-2 spike protein in vitro.